Pikesville
Pikesville
Pikesville, Maryland, United States11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-10-07 | NCT06847321 | |
| MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study | bone disorder, lumbar spinal stenosis, musculoskeletal system disorder, spinal stenosis, vertebral column disorder | Recruiting | Not stated | 2026-09-30 | NCT03072927 | |
| An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Phase 3 | 2026-09-17 | NCT07456696 | |
| A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | Acute Migraine | Recruiting | Phase 3 | 2026-08-27 | NCT07674654 | |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Recruiting | Phase 3 | 2026-08-24 | NCT07000357 | |
| A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Recruiting | Phase 3 | 2026-08-20 | NCT07645924 | |
| Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder | anxiety disorder, phobic disorder, psychiatric disorder, social phobia | Active, not recruiting | Phase 3 | 2026-08-17 | NCT07221578 | |
| Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol | Disorders of Excessive Somnolence, Dyssomnias, Sleep Disorders, Intrinsic, depressive disorder, major depressive disorder, mood disorder, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Phase 3 | 2026-07-24 | NCT07484217 | |
| A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure | Bacterial Infections and Mycoses, Borrelia infectious disease, Infections, Lyme disease, bacterial infectious disease, gram-negative bacterial infections, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-07-09 | NCT07562087 | |
| A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 3 | 2026-05-18 | NCT06709014 | |
| ALTO-207 in Adults With Treatment-resistant Depression (TRD) | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-04-28 | NCT07553637 |